Table 2 Incidence of fungal infections in Poland. Estimation ranges were averaged for clarity and ease of interpretation.
Fungal diseases | Number of fungal infection among patients with underlying diseases | Rate per 100 K | Total (mean) | |||||
|---|---|---|---|---|---|---|---|---|
HIV/AIDS | Respiratory | Cancer/transplant | Hospitalized ICU | Other | ||||
Vulvovaginal candidosis (VVC) | 71,112–294,501 | 430.2 | 161,923 | |||||
Recurrent VVC (rVVC) | 12,324–81,577 | 95.2 | 35,823 | |||||
Oesophageal candidosis (EC) | 347–1462 | 4,708–12,695 | 24.0 | 9054* | ||||
Candida fungaemia | 280–4590 | 7.0 | 2624** | |||||
Candida peritonitis | 930 | 8 | 2.5 | 938 | ||||
Cryptococcosis | 5–6 | 24 | 0.08 | 32 | ||||
Pneumocystis pneumonia (PcP) | 73–172 | 328 | 191 (724) | 1.8 | 669 | |||
Invasive aspergillosis (IA) | 3193–4339 | 1509–1665 | 122–188 | 14.2 | 5353 | |||
Chronic pulmonary aspergillosis (CPA) | 3078 | 132–196 | 8.6 | 3244 | ||||
Allergic bronchopulmonary aspergillosis (ABPA) | 10,337–51,511 | 82.2 | 30,924 | |||||
Severe asthma with fungal sensitization (SAFS) | 8357 | 22.2 | 8357 | |||||
Sinus aspergillosis | 5312 | 14.1 | 5312 | |||||
Mucormycosis | 52–60 | 0.15 | 60 | |||||
Fungal keratitis (FK) | 10–22 | 0.04 | 16 | |||||
Total*** | 272.1 | 102,406 | ||||||
